文献速递临床试验与 GCP流行病学与生物统计真实世界研究与卫生经济

CRADLE-3试验:新型设备管理低资源地区妊娠期高血压和休克的评估方案

Evaluation of a novel device for the management of high blood pressure and shock in pregnancy in low-resource settings: study protocol for a stepped-wedge cluster-randomised controlled trial (CRADLE-3 trial).
PubMed 文献 · Trials · 2018-03-27

CRADLE-3是一项阶梯楔形整群随机对照试验,旨在评估将Microlife® CRADLE生命体征预警设备及培训包纳入常规产科护理后,能否降低中低收入国家孕产妇死亡与严重并发症的复合结局。试验在10个集群开展,每2个月交叉一次,主要结局为每万次分娩中孕产妇死亡、子痫和急诊子宫切除术的复合指标。

要点

  • CRADLE设备整合红绿灯预警系统,帮助各级医护人员早期识别产科出血、脓毒症和妊娠期高血压的血流动力学不稳定。
  • 试验采用阶梯楔形整群随机设计,在10个中低收入国家集群中评估干预对孕产妇死亡与严重并发症复合结局的影响。
  • 干预包括Microlife® CRADLE生命体征预警设备和CRADLE培训包,替代现有设备纳入常规产科护理。

核心结论

  • 该试验旨在确定将CRADLE干预纳入常规产科护理能否降低中低收入国家孕产妇死亡与严重并发症的复合结局。

研究设计与样本

  • CRADLE-3是一项阶梯楔形整群随机对照试验,比较CRADLE干预与常规产科护理。
  • 纳入所有在集群服务区内因产科护理就诊的孕妇或产后6周内妇女。
  • 主要结局为每万次分娩中孕产妇死亡、子痫和急诊子宫切除术的复合指标。
  • 试验参考医学研究理事会复杂干预指南,并进行过程评估和成本效果评估。

关键数值与推荐

  • 主要结局为每10,000次分娩中孕产妇死亡、子痫和急诊子宫切除术的复合结局。
  • 集群包括印度Gokak、Belgaum,津巴布韦Harare,赞比亚Ndola、Lusaka,塞拉利昂Free Town,乌干达Mbale、Kampala,海地Cap Haitien,马拉维South West,埃塞俄比亚Addis Ababa。
  • 干预为Microlife® CRADLE生命体征预警设备及CRADLE培训包,替代现有设备。

临床怎么用

  • 在低资源产科环境中,使用集成红绿灯预警系统的生命体征设备可能帮助各级医护人员早期识别需要升级护理的孕产妇。
  • 干预方案已通过可行性研究优化,具有较低成本和易整合入现有卫生系统的特点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obstetric haemorrhage, sepsis and pregnancy hypertension account for more than 50% of maternal deaths worldwide. Early detection and effective management of these conditions relies on vital signs. The Microlife® CRADLE Vital Sign Alert (VSA) is an easy-to-use, accurate device that measures blood pressure and pulse. It incorporates a traffic-light early warning system that alerts all levels of healthcare provider to the need for escalation of care in women with obstetric haemorrhage, sepsis or pregnancy hypertension, thereby aiding early recognition of haemodynamic instability and preventing maternal mortality and morbidity. The aim of the trial was to determine whether implementation of the CRADLE intervention (the Microlife® CRADLE VSA device and CRADLE training package) into routine maternity care in place of existing equipment will reduce a composite outcome of maternal mortality and morbidity in low- and middle-income country populations. METHODS: The CRADLE-3 trial was a stepped-wedge cluster-randomised controlled trial of the CRADLE intervention compared to routine maternity care. Each cluster crossed from routine maternity care to the intervention at 2-monthly intervals over the course of 20 months (April 2016 to November 2017). All women identified as pregnant or within 6 weeks postpartum, presenting for maternity care in cluster catchment areas were eligible to participate. Primary outcome data (composite of maternal death, eclampsia and emergency hysterectomy per 10,000 deliveries) were collected at 10 clusters (Gokak, Belgaum, India; Harare, Zimbabwe; Ndola, Zambia; Lusaka, Zambia; Free Town, Sierra Leone; Mbale, Uganda; Kampala, Uganda; Cap Haitien, Haiti; South West, Malawi; Addis Ababa, Ethiopia). This trial was informed by the Medical Research Council guidance for complex interventions. A process evaluation was undertaken to evaluate implementation in each site and a cost-effectiveness evaluation will be undertaken. DISCUSSION: All aspects of this protocol have been evaluated in a feasibility study, with subsequent optimisation of the intervention. This trial will demonstrate the potential impact of the CRADLE intervention on reducing maternal mortality and morbidity in low-resource settings. It is anticipated that the relatively low cost of the intervention and ease of integration into existing health systems will be of significant interest to local, national and international health policy-makers. TRIAL REGISTRATION: ISCRTN41244132. Registered on 2 February 2016. Prospective protocol modifications have been recorded and were communicated to the Ethics Committees and Trials Committees. The adapted Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Checklist and the SPIRIT Checklist are attached as Additional file 1.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Nathan HL, Duhig K, Vousden N, et al. Evaluation of a novel device for the management of high blood pressure and shock in pregnancy in low-resource settings: study protocol for a stepped-wedge cluster-randomised controlled trial (CRADLE-3 trial). Trials. 2018. PMID: 29587875. doi:10.1186/s13063-018-2581-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。